Future developments in genetic data analysis for MRA should aim at resolving the mapping problem of processing
genetic sequences to come to a quantitative description of risk. The development of a clustering scheme focusing
on biologically relevant information of the microbe involved would be a useful approach in molecular data reduction
for risk assessment.